Research [ASAP] An Atorvastatin/Ferrostatin-1 Codelivered Hybrid Exosome/Liposome System for Combinational Ferroptosis Inhibition, Inflammation Suppression, Efferocytosis Promotion, and Macrophage Reprogramming in Atherosclerosis Treatment LikeLiked Date: June 12, 2025 Less than 1 MinRead Views: 13 ACS Applied Materials & Interfaces DOI: 10.1021/acsami.5c07617 Source: http://dx.doi.org/10.1021/acsami.5c07617 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles Foodora’s Herbert Haas talks affordable quick commerce and ‘human-centered’ AI in food delivery Food & Agriculture November 11, 2025 Environmental Group Seeks EPA Response on Petition to Revoke Tolerances for Neonics Food & Agriculture November 11, 2025 Multiscale eco-hydrological zoning in the Yarlung Zangbo River Basin, Qinghai–Tibet Plateau, China Research November 11, 2025 Financial feasibility and optimization of anaerobic digestion systems for sustainable waste management: A comprehensive global analysis Research November 11, 2025 Research November 11, 2025 ECB Fines Spanish Bank ABANCA for Not Meeting Climate Risk Expectations Environmental News November 11, 2025 Strategic guide to water innovation launched by Spring Environmental News November 11, 2025 Rotary lobe pumps provide high volume mobile water treatment Environmental News November 11, 2025 Apple Invests in Renewable Energy, Forest Projects in Australia and New Zealand Environmental News November 11, 2025 NiFe-LDH loaded on N-doped Paulownia-derived carbon as a bifunctional oxygen electrocatalyst for rechargeable zinc–air batteries Research November 11, 2025 Load more
